Skip to main content

AC Immune SA Common Stock (ACIU)

About The Company

ACIU Stock Market Logo

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

IPO Year Sector Industry
2016 Health Care Biotechnology: Pharmaceutical Preparations

AC Immune SA (ACIU) Latest News

Company Contact & Address (ACIU)

Corporate Headquarters Phone Website
EPFL INNOVATION PARK BUILDING B,
LAUSANNE,
1015,
Switzerland
+41 216939121 Official ACIU Website

ACIU Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ACIU

Jobs & Employment at AC Immune SA

LinkedIn Company Page https://ch.linkedin.com/company/ac-immune
Official Career & Employment Page Careers, Jobs & Employment at AC Immune SA (ACIU)

Related & Similar Stock Symbols

KRNLW Stock Market Price & News

KRNLW

Kernel Group Holdings Inc. Warrants

DLR Stock Market Price & News

DLR

Digital Realty Trust Inc. Common Stock

NVTS Stock Market Price & News

NVTS

Navitas Semiconductor Corporation Common Stock